Skip to main content

Name 5 Tests or Treatments We Overuse in Geriatrics or Palliative Care

For the most part in geriatrics and palliative care we like to point the finger at other medical providers and say, "STOP."  Stop giving so much chemotherapy.  Stop giving so many medications.  Stop scanning.

But now it's time to take a long hard look in the mirror.

Medical specialty organizations are being asked to come up with a list of 5 tests or treatments that are over-utilized or may actually be harmful.  This effort, called the Choosing Wisely Initiative, is being spearheaded by the American Board of Internal Medicine (ABIM) Foundation.  ABIM President and renowned geriatrician Christine Cassel was quoted in today's New York Times saying:
“In fact, rationing is not necessary if you just don’t do the things that don’t help.”
This same article notes that as much as 1/3 of health care costs are wasted on unnecessary hospitalizations, tests, and treatments.

So far 9 specialty boards have come up with their lists - the boards and there list are here - but Geriatrics and Palliative Medicine are not one of the 9.  Are we really "holier than thou?"  I don't think so.

I suspect we can come up with 5 tests or treatments for each specialty.  It might be more fun to come up with lists for the cardiologists, oncologists, or surgeons, but that's not the point.  Ask not what another specialty should not be doing, but what you can do less of yourself.

It's easier to come up with ideas if you don't think of them as a hard and fast rules (never do x), but as a list of things doctors and patients should question routinely doing in geriatrics or palliative care.

So to jump start things, here are two from each field:

Geriatrics
1. Screening for cancer in patients who are unlikely to benefit.
2. Insulin sliding scales

Palliative Care
1. Using more expensive analgesics without evidence of superiority to less expensive alternatives
2. Using oxygen instead of forced air

Let's figure this out together.  Or someone from another specialty may come up with our list for us!

by: Alex Smith

Comments

Anonymous said…
1. Prescribe docusate.
2. Prescribe more expensive benzodiazepine, e.g. midazolam when a less expensive one is available, e.g. lorazepam.

for starters ...

Paul McIntyre
Halifax, Canada
Nancy Lundebjerg, COO, AGS said…
Thanks Alex for getting this conversation started. AGS will be working on our list over the summer and will be in the second wave of organizations (announcement slated for early fall). I believe AAHPM is on the same timeframe. We welcome everyone's thinking on this topic.
Thank you for calling attention to this initiative. AAHPM is now an official partner of the Choosing Wisely campaign and will be participating in the next round of recommendations (to be released in the fall). Keep an eye on www.aahpm.org for details about how to contribute to the Academy’s process of determining 5 tests and interventions that warrant closer examination by patients and physicians.
Anonymous said…
colace and miralax for opioid related constipation

ongoing use of cholesterol medications when life expectany = months
Eric Widera said…
My number 1:

Videofluoroscopic Swallowing Study to assess swallow function and need for PEG tube placement in individuals with advanced dementia.
Bruce Scott said…
Geriatrics:
Don't administer a Folstein MMSE (saving a buck a test there). :)

Don't initiate hemodialysis in an elderly patient without a thorough discussion of risks and benefits (especially the discussion of likely functional decline).

Institute a nationwide POLST paradigm, and give people who complete one a coupon to Denny's.

Stop the indiscriminate prescription of iron and PPIs associated with hospital admissions (or at minimum review the continued need for them).

Don't do PAP smears on elderly women who have had three consecutive normals.

Don't do colorectal or breast cancer screening on patients with less than 10 year life expectancies (or at least not in those with less than 5 year LEs).

Don't do screening PSAs at all.
Dan Matlock said…
I think I've seen some geriatricians oversell cholinesterase inhibitors. (I know there is data, but "overuse" can also come from overselling benefits and underselling risks)
Helen Chen said…
1. Ordering albumin/prealbumin to check for malnutrition

2. Ordering 'therapeutic' diets for folks with very limited life expectancy or advanced dementia.

3. along the lines of insulin sliding scale, let's stop doing fingerstick glucose checks for folks who won't benefit from tight control, especially on those with limited life expectancy
Anonymous said…
Use of Aricept and other drugs in this class in patients who are bed bound with advanced dementia. Ditto Namenda. Continuing cholesterol lowering medications and Plavix in patients with a 6 month life expectancy. Swallow evals-this has become a whole industry-total waste of time. Low specificity and sensitivity and patients refuse to take the thickened liquids and then get dehydrated. Screening for things not likely to result in improved quality of lie.
Canadian Internist said…
Ordering plain CT scans of the head for elderly patient with a documented history of dementia who are delirious if they are awake without focal findings
walkdoc said…
1. Stop Fosamax/antibone resorptive medications for patients with dementia or bed bound patients.
2. Review reasons for PPI use or continued usage
3. Lipid, EKG, HbA1c mandatory testing by pharmacists for patients on Antipsychotics in severely demented patients or those on hospice care.

Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Delirium: A podcast with Sharon Inouye

In this week's GeriPal podcast we discuss delirium, with a focus on prevention. We are joined by internationally acclaimed delirium researcher Sharon Inouye, MD, MPH. Dr Inouye is Professor of Medicine at Harvard Medical School and Director of the Aging Brain Center in the Institute for Aging Research at Hebrew SeniorLife.

Dr. Inouye's research focuses on delirium and functional decline in hospitalized older patients, resulting in more than 200 peer-reviewed original articles to date. She has developed and validated a widely used tool to identify delirium called the Confusion Assessment Method (CAM), and she founded the Hospital Elder Life Program (HELP) to prevent delirium in hospitalized patients.

We are also joined by guest host Lindsey Haddock, MD, a geriatrics fellow at UCSF who asks a great question about how to implement a HELP program, or aspects of the program, in a hospital with limited resources.  


You can also find us on Youtube!


Listen to GeriPal Podcasts on:
iTunes…

Are Palliative Care Providers Better Prognosticators? A Podcast with Bob Gramling

Estimating prognosis is hard and clinicians get very little training on how to do it.  Maybe that is one of the reasons that clinicians are more likely to be optimistic and tend to overestimate patient survival by a factor of between 3 and 5.  The question is, aren't we better as palliative care clinicians than others in estimating prognosis?  This is part of our training and we do it daily.   We got to be better, right? 

Well, on todays podcast we have Bob Gramling from the Holly and Bob Miller Chair of Palliative Medicine at the University of Vermont to talk about his paper in Journal of Pain and Symptom Management (JPSM) titled “Palliative Care Clinician Overestimation of Survival in Advanced Cancer: Disparities and Association with End of Life Care”.

Big findings from this JPSM paper include that we, like all other clinicians, are an optimistic bunch and that it actually does impact outcomes.   In particular, the people whose survival was overestimated by a palliative care c…